MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Vascular Complications Among Patients Undergoing TAVR
Contemporary concepts facing operators in this challenging patient population.
By Stefan Stortecky, MD, and Peter Wenaweser, MD
Boston Scientific Receives CE Mark Approval for 25-mm Lotus TAVR System
July 14, 2014—Boston Scientific Corporation announced that it has received European CE Mark approval for the 25-mm Lotus transcatheter aortic valve replacement (TAVR) system.
Access and Closure: Focus on TAVR
By Ted E. Feldman, MD, FESC, FACC, FSCAI
CoreValve: Assessing the Clinical Trials
A review of trial patient selection and results, as well as clinical implications.
By Steven J. Yakubov, MD, FACC, and Kyle Feldmann, MD
